Scholarlink

Background <p>Hypertension remains a critical global health challenge, significantly contributing to cardiovascular morbidity and mortality worldwide. A substantial portion of the population continues to experience uncontrolled blood pressure, underlining the need for more tailored care approaches despite the effectiveness of some conventional treatments. This review aims to synthesize the progression of hypertension management, highlighting the shift from conventional, population-based approaches to the emergent era of precision medicine.</p> Methodology <p>A comprehensive literature search (2015–2025) across PubMed, Scopus, Web of Science, and Google Scholar identified English peer-reviewed studies on traditional and precision hypertension management. Using a narrative synthesis, diverse clinical, technological, and policy perspectives were integrated, and visual models illustrated the transition to precision care and its implementation pathways.</p> Results <p>Hypertension remains a major global health burden, especially in low- and middle-income countries, where traditional “one-size-fits-all” management often overlooks genetic, environmental, and treatment-response differences. Precision medicine offers a shift toward individualized care using genomic and digital data but faces barriers such as cost, infrastructure, and data inequities.</p> Conclusion <p>Gradual integration of precision tools within strong health systems and equitable policies offers the best path to improving hypertension care globally. Collaborative efforts among clinicians, researchers, and policymakers are needed to build evidence, ensure accessibility, and promote equity. The next decade should focus on multi-ethnic studies, cost-effectiveness analyses, and integrating precision tools within population-based health systems for balanced, evidence-driven implementation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hypertension care in the era of precision medicine: a review of the shift from traditional approaches and global health implications

  • 期刊论文

  • 发表日期：

    2025年12月19日

查看全文
  • Oluwafisayomi Victoria Oso,
  • Uthman Okikiola Adebayo,
  • David Toluwani Ajayi,
  • Emmanuel Ayomide Oluwasusi,
  • Titilayo Oluwaseun Jegede,
  • Emmanuella Ogechi Onyeaghala,
  • Praise Dorcas Agun,
  • Samuel Opeyemi Oyetunji,
  • Precious Miracle Wagwula

摘要

Background

Hypertension remains a critical global health challenge, significantly contributing to cardiovascular morbidity and mortality worldwide. A substantial portion of the population continues to experience uncontrolled blood pressure, underlining the need for more tailored care approaches despite the effectiveness of some conventional treatments. This review aims to synthesize the progression of hypertension management, highlighting the shift from conventional, population-based approaches to the emergent era of precision medicine.

Methodology

A comprehensive literature search (2015–2025) across PubMed, Scopus, Web of Science, and Google Scholar identified English peer-reviewed studies on traditional and precision hypertension management. Using a narrative synthesis, diverse clinical, technological, and policy perspectives were integrated, and visual models illustrated the transition to precision care and its implementation pathways.

Results

Hypertension remains a major global health burden, especially in low- and middle-income countries, where traditional “one-size-fits-all” management often overlooks genetic, environmental, and treatment-response differences. Precision medicine offers a shift toward individualized care using genomic and digital data but faces barriers such as cost, infrastructure, and data inequities.

Conclusion

Gradual integration of precision tools within strong health systems and equitable policies offers the best path to improving hypertension care globally. Collaborative efforts among clinicians, researchers, and policymakers are needed to build evidence, ensure accessibility, and promote equity. The next decade should focus on multi-ethnic studies, cost-effectiveness analyses, and integrating precision tools within population-based health systems for balanced, evidence-driven implementation.